US$ 27.65
obesity drugs glp-1 news today New research is challenging long-held assumptions about in weight loss treatments. A different approach may be emerging. Click the link in bio to read the full story The GLP-1 revolution: What UAB
Description
Indication: Primarily used for chronic idiopathic constipation in adults especially when laxatives fail to provide adequate relief

Small Seeds, Big Fiber When you cant eat much, look for concentrated sources of fiber

Microdosing protocols vary from person to person, but most people start with 0.05mg to 0.25mg per week
Diabetics should not be competing for life-saving diabetes drugs with people looking to lose weight

Key takeaways include: Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under fee-for-service (FFS) as of January 2026